- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06752980
The Effect of Eye Mask and Earplugs on Sleep Quality and Delirium in Coronary Artery Bypass Graft Patients: A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Saide Faydalı
- Phone Number: +905056652357
- Email: sdfydl@gmail.com
Study Contact Backup
- Name: zeliha Birer
- Phone Number: +95308753846
Study Locations
-
-
Konya
-
Selçuklu, Konya, Turkey, 42208
- Necmettin Erbakan Universıty
-
Contact:
- Email: zeliha.birer.48@gmail.com
-
Principal Investigator:
- zeliha Birer
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
-Patients who voluntarily agree to participate in the study
- Those who have undergone coronary artery bypass graft surgery
- Those between the ages of 18-79
- Those who are cooperative and oriented
- Those who are literate
- Those who speak Turkish
- Those whose initial delirium scale score (Nu-DECS) is less than 2
- Those whose Glasgow coma scale score is >13 will be included in the study.
Exclusion Criteria:
• Patients diagnosed with sleep disorders,
- Those using sleeping pills,
- Those who have a habit of using an eye patch while sleeping,
- Those who were not transferred to the clinic on the first day after surgery and whose treatment continues in the intensive care unit,
- Those who develop complications and/or need to be re-operated,
- Those who need treatment other than routine treatment,
- Patients with hearing or vision problems will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Eye Mask and Earplugs
On the 1st, 2nd and 3rd postoperative day, the experimental group will be given the intervention reserved during their night sleep, using eye patches and earplugs. On the 2nd, 3rd and 4th postoperative day, repeated monitoring will be performed using RCUÖ and Nu-DESC. Patients who wish to leave the study at any stage, do not receive the reserved intervention or die during the monitoring will be excluded from the study. |
The three experimental groups (eye patch group, earplug group, eye patch and earplug group applied together) will be given a separate intervention during their night sleep on the 1st, 2nd and 3rd postoperative day.
Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th postoperative days.
|
|
Experimental: Earplugs
The reserved intervention will be applied during the night sleep with earplugs on the 1st, 2nd and 3rd day group after the surgery. Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after the surgery. Patients who want to leave at any stage of the study, do not receive the reserved intervention or die during the monitoring will be excluded from the study. |
The three experimental groups (eye patch group, earplug group, eye patch and earplug group applied together) will be given a separate intervention during their night sleep on the 1st, 2nd and 3rd postoperative day.
Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th postoperative days.
|
|
Experimental: Eye Mask
The intervention allocated during night sleeps with Eye Mask applied on the 1st, 2nd and 3rd days after the surgery will be applied. Repeated monitoring will be done using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after the surgery. Patients who want to leave at any stage of the study, do not perform the allocated intervention or die during the follow-up will be excluded from the study. |
The three experimental groups (eye patch group, earplug group, eye patch and earplug group applied together) will be given a separate intervention during their night sleep on the 1st, 2nd and 3rd postoperative day.
Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th postoperative days.
|
|
No Intervention: no mask no earblugs
No intervention will be performed on the 1st, 2nd and 3rd postoperative day. Repeated monitoring will be performed on the 2nd, 3rd and 4th postoperative day using RCUÖ and Nu-DESC. Patients who wish to leave the study at any stage, who do not perform the intervention, or who die during follow-up will be excluded from the study. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Richards-Campbell Sleep Scale
Time Frame: Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after surgery.
|
The RCUS was developed by Richards and colleagues (1987) to assess sleep.
The RCUS includes six items (sleep depth, time to fall asleep, frequency of awakenings, time to remain awake when awakened, quality of sleep, and ambient noise level).
Each item is rated using a 0-100 visual analog scale.
The total score is obtained by dividing the individual items by their numbers: 0 represents the worst sleep, 100 the best sleep.
As the score obtained from the scale increases, the sleep quality of the patients also increases.
The RCUS provides a short, applicable, comprehensive, and simple tool for assessing sleep quality in the intensive care unit and is the most common.
The Cronbach α value of the scale was found to be 0.82.
The validity and reliability study of the scale in our country was conducted by Karaman Özlü and Özer (2015).
The Cronbach Alpha internal consistency coefficient of the scale was found to be 0.91.
|
Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after surgery.
|
|
Nursing Delirium Screening Scale- Nu-DESC
Time Frame: Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after surgery.
|
The scale consists of five items.
These are; disorientation, inappropriate behavior, inappropriate communication, illusion-hallucination and slowness in psychomotor behavior.
It is critical that all subtypes can be detected in an effective delirium diagnosis.
Among the items in Nu-DESC, it is thought that hypoactive delirium is detected more successfully with the item that evaluates psychomotor slowness.
Each item in the scale takes a value between 0 and 2 points and the total score varies between 0 and 10.
Two points and above indicate delirium.
The evaluation time is approximately one minute.
|
Repeated monitoring will be performed using RCUÖ and Nu-DESC on the 2nd, 3rd and 4th days after surgery.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Saide Faydalı, Necmeetin Erbakan University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NecmettinEU-SBF-ZB-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Surgical Procedures
-
University Health Network, TorontoSunnybrook Health Sciences Centre; McMaster University; Unity Health Toronto; The... and other collaboratorsActive, not recruitingAlbumin | Cardiovascular Surgical ProceduresCanada
-
Meshalkin Research Institute of Pathology of CirculationCompletedIntensive Care | Cardiovascular Surgical ProceduresRussian Federation
-
Ethicon Endo-SurgeryRecruitingAdult Gynecological Procedures | Adult Urological Procedures | Adult Thoracic Procedures | Pediatric Surgical Procedures | Adult Surgical ProceduresCanada, United Kingdom, United States
-
Nanjing Medical UniversityThe First Affiliated Hospital with Nanjing Medical University; West China Hospital and other collaboratorsNot yet recruitingCardiovascular Surgical Procedures | Major Adverse Cardiovascular Events (MACE)China
-
MedtronicCompletedSurgical Procedures, Operative | Minimally Invasive Surgical ProceduresUnited States
-
Samsung Medical CenterCompletedSternotomy | Cardiac Surgical Procedures | Thoracic Surgical ProceduresKorea, Republic of
-
Hospices Civils de LyonCompleted
-
University of MichiganNot yet recruitingPediatric Surgical ProceduresUnited States
-
Wuhan Union Hospital, ChinaRecruitingCardiac Surgical ProceduresChina
-
Clinique du MillenaireNot yet recruitingCardiac Surgical Procedures
Clinical Trials on Eye Mask and Earplugs
-
Baskent UniversityActive, not recruiting
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingOrthopedic Surgery | Comfort | Nursing Care | Quality of Recovery 40
-
Duke UniversityCompleted
-
Boston Medical CenterWithdrawn
-
Melek YÜKSELEge UniversityNot yet recruitingAnxiety Physiological Stress Responses ,Fiberoptic Bronchoscopy, Sensory IsolationTurkey (Türkiye)
-
Shin Kong Wu Ho-Su Memorial HospitalCompletedSleep Quality | Circadian Rhythm | Intensive Care Unit | VentilatorTaiwan
-
Ege UniversityCompletedBrain Trauma | Joint Trauma | Cervical Injury Spine | Thorax InjuriesTurkey (Türkiye)
-
Bozok UniversityCompletedPain Management | Pediatric Delirium | Pediatric Intensive Care Unit | Critical Care Nursing | Non-Pharmacological InterventionsTurkey (Türkiye)
-
Assiut UniversityUnknown
-
Hamideh SabbaghiNot yet recruitingDry Eye DiseaseIran, Islamic Republic of